PATENT CLAIM ANALYSIS

Application Number: 15920885
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "035000"]

Abstract:
Embodiments disclosed herein provide compositions and methods for treating lymphangioleiomyomatosis (LAM) comprising inhibiting COX overexpression and prostaglandin over production by administering at least one COX inhibitor and/or prostaglandin biosynthetic pathway inhibitors.

Claim (Index 61):
The composition of  claim 6 , further comprising at least one pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.09677
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14771817', '15305883', '12989529', '13520472', '10639263']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7691690779470104
- 35 USC 102 Novelty (BERT): 0.602938211180383
- Combined Prediction Score: 0.7525459912703476
- Mean Citation Score: 362.809348
- Max Citation Score: 751.68854
- Similarity Product: 441.1784117153585

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test